# Alternative Dosing Strategy for Anti-HIV Drugs

> **NCT00059384** · PHASE4 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 66 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BEHAVIORAL:** Concentration-controlled therapy

## Key facts

- **NCT ID:** NCT00059384
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 66 (—)
- **Last updated:** 2008-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00059384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00059384, "Alternative Dosing Strategy for Anti-HIV Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00059384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*